Oppenheimer Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $73

Moomoo NewsJan 13 08:35 ET · Ratings

H.C. Wainwright Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $81

Moomoo NewsJan 13 06:31 ET · Ratings

A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $55 to $92

Moomoo NewsJan 11 08:00 ET · Ratings

Express News | Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersJan 10 17:15 ET

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireJan 10 17:15 ET

Crinetics Data 'Compelling' Despite Safety Concerns, Says Leerink

TipRanksJan 10 14:50 ET